高機能医療用プラスチックの世界市場、2030年までの予測：原材料別、用途別、地域別

Stratistics MRCによると、高機能医療用プラスチックの世界市場は2024年に11億5,000万米ドルを占め、予測期間中のCAGRは10.4％で成長し、2030年には20億8,000万米ドルに達する見込みです。

高機能医療用プラスチックは、医療用途の厳しい要件を満たすために特別に設計された高度なポリマー材料です。これらの材料は、卓越した強度、耐久性、生体適合性を示し、医療機器、インプラント、手術器具での使用に理想的です。高機能医療用プラスチックは、滅菌法に対する耐性、様々な体液との適合性、精密成形能力などの特性を備えており、複雑で信頼性の高い医療機器の作成を可能にしています。

WHO2021によると、毎年約130万人が交通事故により死亡し、さらに約2,000万～5,000万人が死亡に至らない怪我を負い、その多くが怪我による障害を経験しています。

環境の持続可能性に関する意識の高まり

従来のプラスチックが生態系に及ぼす影響に対する意識が高まるにつれ、ヘルスケアを含む産業界は持続可能な代替品に軸足を移しつつあります。耐久性、生体適合性、滅菌能力で有名な高機能医療用プラスチックは、採用が急増しています。これらの素材は、環境への影響を最小限に抑えながら、ヘルスケア分野の厳しい品質・安全基準に適合する、説得力のあるソリューションを提供します。メーカーは、これらのプラスチックの持続可能性プロファイルをさらに強化するための研究開発に投資しており、市場の成長を促進しています。

材料不良のリスク

高機能医療用プラスチック（HPMP）の進歩には、材料破損のリスクが大きな課題となっています。これらの材料は、生体適合性、耐久性、耐薬品性などの優れた特性により、様々な医療用途において極めて重要です。医療用途の厳しい条件下での信頼性の確保は不可欠です。しかし、材料の不具合は、性能の低下、患者への危害の可能性、メーカーのコスト増につながる可能性があります。過酷な化学物質への長期的な曝露、繰り返される滅菌処理、使用中の機械的ストレスなどの要因が、故障のリスクにつながります。

患者専用インプラントの開発

患者専用インプラントの開発は、高機能医療用プラスチックの台頭の大きな原動力となっています。これらのインプラントは、個々の患者の解剖学的仕様に合わせたもので、従来の画一的なインプラントに比べて優れた適合性と性能を発揮します。高機能医療用プラスチックは、その汎用性、生体適合性、耐久性により、このカスタマイズプロセスにおいて重要な役割を果たしています。これらの材料は、人体組織の特性を模倣するように精密に設計することができ、必要な構造的サポートを提供しながら、体内での最適な統合を保証します。さらに、軽量設計、耐腐食性、柔軟性などの利点もあり、幅広い医療用途に理想的です。

コストの制約

高機能医療用プラスチックの進歩には、コスト上の制約が大きな障害となっています。これらの材料は、医療業界が求める厳しい安全基準や性能基準を満たすために、特殊な配合や製造工程を必要とすることが多いです。コストを抑えながらこれらの基準を達成することは、大きな課題です。高品質の原材料、精密な製造技術、厳格な品質管理対策はすべて、製造コストの上昇につながります。その結果、優れた性能特性を持つ革新的な医療用プラスチックの開発と採用は、手頃な価格と機能性のバランスを取る必要性によって制限される可能性があります。

COVID-19の影響：

COVID-19の大流行は、人工呼吸器、顔面シールド、医療用包装などの医療機器の需要が急増したため、高機能医療用プラスチック市場に大きな影響を与え、それらの製造に使用される高機能医療用プラスチックの需要を押し上げました。しかし、閉鎖や規制による世界のサプライチェーンの混乱は、原材料の調達に課題をもたらし、生産能力に支障をきたしています。全体として、パンデミックは課題をもたらしましたが、同時に技術革新を加速させ、ヘルスケア用途における高機能医療用プラスチックの重要な役割を浮き彫りにしました。

予測期間中はポリスルホンセグメントが最大になる見込み

ポリスルホン分野は予測期間中に最大となる見込みです。高性能熱可塑性プラスチックであるポリスルホンは、その優れた特性により医療用プラスチック市場に革命をもたらしています。優れた強度、耐薬品性、生体適合性により、さまざまな医療用途に最適です。手術器具、カテーテル、血液透析膜などの医療機器において、ポリスルホンは比類のない耐久性と信頼性を発揮します。劣化することなく繰り返される滅菌サイクルに耐えることができるため、製品の寿命と安全性が保証され、ヘルスケア環境では極めて重要です。

ドラッグデリバリー分野は予測期間中に最も高いCAGRが見込まれる

ドラッグデリバリー分野は、予測期間中に最も高いCAGRが見込まれます。生体適合性、耐久性、汎用性で知られる高機能医療用プラスチックは、ドラッグデリバリーシステムの理想的な材料として役立ちます。これらのプラスチックは、効率と精度を高めて医薬品を封入・送達するよう精密に設計することができます。さらに、標的を絞ったドラッグデリバリーを可能にすることで、全身的な副作用を最小限に抑え、患者の転帰を改善することができます。高度な製造技術により、特定の治療ニーズに合わせたインプラント、マイクロスフェア、パッチなどの複雑なドラッグデリバリーデバイスの製造が可能になります。

最大のシェアを占める地域

金属やガラスといった従来の材料に比べ、汎用性、軽量性、費用対効果に優れていることから、医療機器にプラスチック部品を採用するケースが増えています。医療技術の進歩に伴い、生体適合性、耐久性、滅菌プロセスへの耐性といった優れた性能特性を備えながら、厳しい規制基準を満たすことができる材料が求められています。さらに、高機能医療用プラスチックはこうした基準を満たすため、カテーテルから手術器具に至るまで、さまざまな医療機器の製造に欠かせないものとなっています。

CAGRが最も高い地域：

アジア太平洋地域は、予測期間中に力強い成長を遂げると推定されます。医療機器や装置に安全で高品質な材料の使用を義務付ける厳しい規制が、メーカーに高度な医療グレードのプラスチックを選択するよう促しています。こうした規制は、医療機器が厳格な安全・性能基準を満たしていることを保証するものであり、同地域における高機能医療用プラスチックの需要を牽引しています。ヘルスケア関連感染の減少に重点を置いた規制上の取り組みが、医療用途での抗菌・滅菌プラスチックの採用に拍車をかけています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査情報源
  • 1次調査情報源
  • 2次調査情報源
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 用途分析
• 新興市場
• COVID-19の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の高機能医療用プラスチック市場：原材料別

• ポリスルホン
• ポリプロピレン
• ポリカーボネート
• ポリフェニレンサルファイド
• その他

第6章 世界の高機能医療用プラスチック市場：用途別

• ドラッグデリバリー
• 補綴・インプラント
• 医療機器・ツール
• 医療用ディスポーザブル
• その他

第7章 世界の高機能医療用プラスチック市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東・アフリカ

第8章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品発売
• 事業拡大
• その他の主要戦略

第9章 企業プロファイリング

• BASF SE
• Bayer AG
• DuPont
• Eastman Chemical Company
• Evonik Industries AG
• Lubrizol Corporation
• Mitsubishi Chemical Corporation
• Raumedic AG
• Rochling SE & Co. KG
• Saint-Gobain Performance Plastic
• The Chemours Company
• Victrex PLC

List of Tables

• Table 1 Global High Performance Medical Plastics Market Outlook, By Region (2022-2030) ($MN)
• Table 2 Global High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
• Table 3 Global High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
• Table 4 Global High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
• Table 5 Global High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
• Table 6 Global High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
• Table 7 Global High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
• Table 8 Global High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
• Table 9 Global High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
• Table 10 Global High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
• Table 11 Global High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
• Table 12 Global High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
• Table 13 Global High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 14 North America High Performance Medical Plastics Market Outlook, By Country (2022-2030) ($MN)
• Table 15 North America High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
• Table 16 North America High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
• Table 17 North America High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
• Table 18 North America High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
• Table 19 North America High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
• Table 20 North America High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
• Table 21 North America High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
• Table 22 North America High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
• Table 23 North America High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
• Table 24 North America High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
• Table 25 North America High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
• Table 26 North America High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 27 Europe High Performance Medical Plastics Market Outlook, By Country (2022-2030) ($MN)
• Table 28 Europe High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
• Table 29 Europe High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
• Table 30 Europe High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
• Table 31 Europe High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
• Table 32 Europe High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
• Table 33 Europe High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
• Table 34 Europe High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
• Table 35 Europe High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
• Table 36 Europe High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
• Table 37 Europe High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
• Table 38 Europe High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
• Table 39 Europe High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 40 Asia Pacific High Performance Medical Plastics Market Outlook, By Country (2022-2030) ($MN)
• Table 41 Asia Pacific High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
• Table 42 Asia Pacific High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
• Table 43 Asia Pacific High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
• Table 44 Asia Pacific High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
• Table 45 Asia Pacific High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
• Table 46 Asia Pacific High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
• Table 47 Asia Pacific High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
• Table 48 Asia Pacific High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
• Table 49 Asia Pacific High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
• Table 50 Asia Pacific High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
• Table 51 Asia Pacific High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
• Table 52 Asia Pacific High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 53 South America High Performance Medical Plastics Market Outlook, By Country (2022-2030) ($MN)
• Table 54 South America High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
• Table 55 South America High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
• Table 56 South America High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
• Table 57 South America High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
• Table 58 South America High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
• Table 59 South America High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
• Table 60 South America High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
• Table 61 South America High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
• Table 62 South America High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
• Table 63 South America High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
• Table 64 South America High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
• Table 65 South America High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 66 Middle East & Africa High Performance Medical Plastics Market Outlook, By Country (2022-2030) ($MN)
• Table 67 Middle East & Africa High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
• Table 68 Middle East & Africa High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
• Table 69 Middle East & Africa High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
• Table 70 Middle East & Africa High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
• Table 71 Middle East & Africa High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
• Table 72 Middle East & Africa High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
• Table 73 Middle East & Africa High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
• Table 74 Middle East & Africa High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
• Table 75 Middle East & Africa High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
• Table 76 Middle East & Africa High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
• Table 77 Middle East & Africa High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
• Table 78 Middle East & Africa High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)

According to Stratistics MRC, the Global High Performance Medical Plastics Market is accounted for $1.15 billion in 2024 and is expected to reach $2.08 billion by 2030 growing at a CAGR of 10.4% during the forecast period. High-performance medical plastics are advanced polymer materials specifically engineered to meet stringent requirements for medical applications. These materials exhibit exceptional strength, durability, and biocompatibility, making them ideal for use in medical devices, implants, and surgical instruments. High-performance medical plastics offer properties such as resistance to sterilization methods, compatibility with various bodily fluids, and precision molding capabilities, enabling the creation of intricate and reliable medical devices.

According to the WHO 2021, around 1.3 million people die each year due to road traffic crashes and around 20 to 50 million more people suffer non-fatal injuries, with many experiencing a disability due to their injury.

Market Dynamics:

Driver:

Increasing awareness about environmental sustainability

With increasing awareness about the ecological repercussions of traditional plastics, industries, including healthcare, are pivoting towards sustainable alternatives. High performance medical plastics, renowned for their durability, biocompatibility, and sterilization capabilities, are witnessing a surge in adoption. These materials offer a compelling solution, aligning with the healthcare sector's stringent quality and safety standards while minimizing environmental impact. Manufacturers are investing in research and development to enhance the sustainability profile of these plastics further, catalyzing market growth.

Restraint:

Risk of material failure

The risk of material failure poses a significant challenge to the advancement of High Performance Medical Plastics (HPMP). These materials are crucial in various medical applications due to their superior properties like biocompatibility, durability, and resistance to chemicals. Ensuring their reliability under the demanding conditions of medical use is essential. However, material failures can lead to compromised performance, potential harm to patients, and increased costs for manufacturers. Factors such as long-term exposure to harsh chemicals, repeated sterilization processes, and mechanical stresses during use contribute to the risk of failure.

Opportunity:

Development of patient specific implants

The development of patient-specific implants has been a significant driving force behind the rise of high-performance medical plastics. These implants are tailored to individual patients' anatomical specifications, offering better compatibility and performance compared to traditional, one-size-fits-all implants. High-performance medical plastics play a crucial role in this customization process due to their versatility, biocompatibility, and durability. These materials can be precisely engineered to mimic the properties of human tissues, ensuring optimal integration within the body while providing necessary structural support. Additionally, they offer advantages such as lightweight design, resistance to corrosion, and flexibility, making them ideal for a wide range of medical applications.

Threat:

Cost constraints

Cost constraints pose a significant hindrance to the advancement of high-performance medical plastics. These materials often require specialized formulations and production processes to meet stringent safety and performance standards demanded by the medical industry. Achieving these standards while keeping costs low presents a considerable challenge. High-quality raw materials, precise manufacturing techniques, and rigorous quality control measures all contribute to elevated production expenses. As a result, the development and adoption of innovative medical plastics with superior performance characteristics may be limited by the need to balance affordability with functionality.

Covid-19 Impact:

The Covid-19 pandemic has significantly impacted the High Performance Medical Plastics market due to the surge in demand for medical equipment such as ventilators, face shields, and medical packaging has boosted the demand for high-performance medical plastics used in their manufacturing. However, disruptions in the global supply chain due to lockdowns and restrictions have led to challenges in sourcing raw materials and hindered production capacities. Overall, while the pandemic has posed challenges, it has also accelerated innovation and highlighted the critical role of high-performance medical plastics in healthcare applications.

The Polysulfone segment is expected to be the largest during the forecast period

Polysulfone segment is expected to be the largest during the forecast period. Polysulfone, a high-performance thermoplastic, is revolutionizing the medical plastics market due to its exceptional properties. Its superior strength, chemical resistance, and biocompatibility make it ideal for various medical applications. In medical devices, such as surgical instruments, catheters, and hemodialysis membranes, polysulfone offers unmatched durability and reliability. Its ability to withstand repeated sterilization cycles without degradation ensures product longevity and safety, crucial in healthcare settings.

The Drug Delivery segment is expected to have the highest CAGR during the forecast period

Drug Delivery segment is expected to have the highest CAGR during the forecast period. High performance medical plastics, known for their biocompatibility, durability, and versatility, serve as ideal materials for drug delivery systems. These plastics can be precisely engineered to encapsulate and deliver pharmaceuticals with increased efficiency and accuracy. Moreover, they enable targeted drug delivery, minimizing systemic side effects and improving patient outcomes. Advanced manufacturing techniques allow for the production of intricate drug delivery devices, such as implants, microspheres, and patches, tailored to specific therapeutic needs.

Region with largest share:

North America region commanded the largest share of the market during the extrapolated period, as medical devices are increasingly incorporating plastic components due to their versatility, lightweight nature, and cost-effectiveness compared to traditional materials like metal or glass. The advancements in medical technology require materials that can meet stringent regulatory standards while offering superior performance characteristics such as biocompatibility, durability, and resistance to sterilization processes. Furthermore, high-performance medical plastics fulfill these criteria, making them indispensable in the production of various medical devices ranging from catheters to surgical instruments.

Region with highest CAGR:

Asia Pacific region is estimated to witness robust growth over the projection time frame. Stringent regulations mandating the use of safe and high-quality materials in medical devices and equipment are prompting manufacturers to opt for advanced medical-grade plastics. These regulations ensure that medical devices meet strict safety and performance standards, driving the demand for high-performance medical plastics in the region. Regulatory initiatives focused on reducing healthcare-associated infections are spurring the adoption of antimicrobial and sterilizable plastics in medical applications.

Key players in the market

Some of the key players in High Performance Medical Plastics market include BASF SE, Bayer AG, DuPont, Eastman Chemical Company, Evonik Industries AG, Lubrizol Corporation, Mitsubishi Chemical Corporation, Raumedic AG, Rochling SE & Co. KG, Saint-Gobain Performance Plastic, The Chemours Company and Victrex PLC.

Key Developments:

In March2024, Evonik Industries AG and Vland Biotech Begin Joint Venture. The venture aims to expand the market presence of their livestock probiotics in Greater China and develop new products. Evonik's biotech platform is dedicated to creating biosolutions for healthier living. It innovates at the crossroads of chemistry, biotechnology, pharmacology, and data science.

In June2023, The Lubrizol Corporation will invest over $150 million (about ₹1,200 crore) across different projects in India. According to the specialty chemicals maker, the investments will be made into setting up CPVC (chlorinated polyvinyl chloride) resin plant in Vilayat, doubling the capacity at its site in Dahej in Gujarat and opening a grease lab in Navi Mumbai.

Raw Materials Covered:

• Polysulfone
• Polypropylene
• Polycarbonate
• Polyphenylene Sulfide
• Other Raw Materials

Applications Covered:

• Drug Delivery
• Prosthetics & Implants
• Medical Equipment & Tools
• Medical Disposables
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global High Performance Medical Plastics Market, By Raw Material

• 5.1 Introduction
• 5.2 Polysulfone
• 5.3 Polypropylene
• 5.4 Polycarbonate
• 5.5 Polyphenylene Sulfide
• 5.6 Other Raw Materials

6 Global High Performance Medical Plastics Market, By Application

• 6.1 Introduction
• 6.2 Drug Delivery
• 6.3 Prosthetics & Implants
• 6.4 Medical Equipment & Tools
• 6.5 Medical Disposables
• 6.6 Other Applications

7 Global High Performance Medical Plastics Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 BASF SE
• 9.2 Bayer AG
• 9.3 DuPont
• 9.4 Eastman Chemical Company
• 9.5 Evonik Industries AG
• 9.6 Lubrizol Corporation
• 9.7 Mitsubishi Chemical Corporation
• 9.8 Raumedic AG
• 9.9 Rochling SE & Co. KG
• 9.10 Saint-Gobain Performance Plastic
• 9.11 The Chemours Company
• 9.12 Victrex PLC